Why does this broker see another 33% upside in the QBE share price?

The insurer looks set to deliver considerable upside, according to more than one broker.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • QBE shares continue powering home in 2022, despite ending in the red today
  • Brokers are bullish with the overwhelming majority saying to buy the stock at its current levels
  • In the last 12 months, the QBE share price has gained more than 17%

The QBE Insurance Group Ltd (ASX: QBE) share price closed 1.12% lower at $12.37 on Wednesday.

After a shaky period in 2021, QBE shares have rebounded once again, gaining almost 9% this year to date.

Meanwhile, in wider market moves, the S&P/ASX 200 Financials index (ASX: XFJ) closed down 1.08% today at 6,495.5.

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop.

Image source: Getty Images

More upside for QBE to come?

According to the team at JP Morgan, that could very well be the case. Its analysts are baking in considerable upside for QBE in 2022.

"As a global commercial insurer, QBE is subject to the vagaries of the insurance cycle and volatile natural catastrophes," the broker said in a recent note.

"Trends in the cycle are currently improving, and there could be further upside from premium rates, providing a tailwind for earnings growth, with investment yields a headwind," it added.

Building the case for JP Morgan was QBE's income derived from gross written premium (GWP) in the previous quarter. It grew 19% on the prior corresponding period.

As a result, it has increased its earnings estimates for the company from 2023. Its analysts said:

We have increased earnings in CY23 approximately 10% due predominantly to some upside on yields and strong GWP.

CY22 earnings are impacted by perils and the run-off insurance contracts, offset by higher yields, leaving no room for material changes.

Upside catalysts include more success at taking expense and claim costs out of the business than we give credit for, a quick turnaround in the economy, a limited impact from COVID-19-related losses, stronger premium rate increases, and global interest rates holding up better than currently expected.

Consequently JP Morgan is overweight on QBE shares and urges its clients to buy at the current levels, valuing the company at $16.50 per share – an upside potential of 33% from the current share price.

JP Morgan is joined by an extensive list of 10 analysts also advocating buying the stock. That's 91% of coverage with just one broker saying to hold, according to Bloomberg data. There are no sell ratings on this list.

Meanwhile, QBE shares continue powering on, and have now rushed 17% higher in the last 12 months after this most recent bull run.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Man sitting in a plane seat works on his laptop.
Broker Notes

Down 34% in 2026, are Virgin Australia shares a good buy today?

A leading analyst delivers his outlook for Virgin Australia’s beaten-down shares.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »